Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures

Sponsor
Assuta Ashdod Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05941390
Collaborator
(none)
270
3
12

Study Details

Study Description

Brief Summary

A randomized control trial will be conducted in Assuta Ashdod hospital, in the department of obstetrics and gynecology . After signing an informed consent form pregnant and non pregnant women, undergoing one of the procedures (external cephalic version,amniocentesis or hysteroscopy) will be included in the study.

After randomization in to three arms controles without vr goggles , the intervention group second arm using vr goggles showing short film without sound .Third arm intervention group will use vr goggles with sound a short relaxing sentences taking from the positive psychology.

Before and after the procedure each group will answer pain and anxiety questionnaires adiitionaly at the end of each procedure cortisol level in saliva will be measured.

Condition or Disease Intervention/Treatment Phase
  • Other: VR without sound
  • Other: VR with sound
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
270 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Using Virtual Reality (VR) Technology in Gynecological Procedures
Anticipated Study Start Date :
Jul 4, 2023
Anticipated Primary Completion Date :
Jul 4, 2024
Anticipated Study Completion Date :
Jul 4, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: controls

patient who will undergone one of the procedures without using VR

Active Comparator: VR without sound

patient who will undergone one of the procedures using VR without sound

Other: VR without sound
using VR googles showing relaxing short videos without sounds

Active Comparator: VR with sound

patient who will undergone one of the procedures using VR with sound

Other: VR with sound
using VR googles showing relaxing short videos with positive psychological audio

Outcome Measures

Primary Outcome Measures

  1. stress cortisol saliva level [up to 5 minutes after the procedure]

    each arm after the procedure will be mesured stress cortisol level in saliva

Secondary Outcome Measures

  1. pain levels [up to 5 minutes after]

    each arm after the procedure will fill pain questioner. pain questioners using visual analog score. 0- to 10, while 0 is no pain at all, 10 is the worse pain ever felt.the patients will fill the questioner before and after the procedures.

  2. anxiety levels [up to 5 minutes after]

    each arm after the procedure will fill anxiety questioner. anxiety questioner using the short depression , anxiety and stress scale (DASS-21). the patients will fill the questioners before and after the procedures.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ECV- single tone, breech presentation,gestional age 35-40,unknown drug allergy

  • amniocintesis -single tone,gestional age 16-24 week,

  • hysteroscopy-women age 18-60 , diagnostic procedure,

Exclusion Criteria:
  • ECV-previous cesarian section, contruction,low known plt count ,premature rupture of membrane

  • amniocintesis- Known fetal malformations, amnionitis

  • hysteroscopy-pregnancy, PID

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assuta Ashdod Hospital

Investigators

  • Principal Investigator: Noa glick fishman, MD, Assuta Ashdod

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Assuta Ashdod Hospital
ClinicalTrials.gov Identifier:
NCT05941390
Other Study ID Numbers:
  • 0125-22-AAA
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 12, 2023